Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-7847 for prevention of chemotherapy-induced nausea and vomiting in pediatric patients
jRCT2080221850Phase 3Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of fosaprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by Ono Pharmaceutical. Started Jul 2012; status: completed.
02
Drugs
fosaprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on jRCT2080221850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221850.